ASH 2022: Lab-Based Clinical Trial Eligibility Criteria More Likely to Exclude Minorities
Hemoglobin had the largest impact on eligibility for non-White patients with diffuse large B-cell lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.